| Name | Title | Contact Details |
|---|
Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.
Specialty Media provides innovative products and services of the highest quality to the academic and industrial biological research community. Our products and services are designed with the needs of the bench researcher in mind. Specialty Media offers
ShapeUp is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Providence, RI. To find more information about ShapeUp, please visit www.shapeup.com
Access Physicians is a physician-founded, multispecialty group that is improving outcomes by increasing access to exceptional care through telemedicine.
DUOS is reimagining freedom at any age. As a technology-enabled service provider, DUOS connects people to the essential resources required to attain the highest level of health. Our advanced technology allows us to aggregate historically siloed data and resources from across the ecosystem, breaking down barriers to health literacy and access to care and enabling seamless and timely connections with complete visibility and feedback throughout the process.